Bristol-Myers Squibb Company(BMY)
73.16
Change: -1.14 (▼ -1.56%)
As of Tue 12/20/2022 03:45 PM% Of Value
Growth
Value Per Share
:
:
:
-669.12
9.09
24.9900 (as of 19/12/2022)
Fundamentals Data
| Open | 73.66 | Dividend | 1680 |
| Close Price | 73.16 | DivYield | 2.75 % |
| High | 74.23 | Growth | 3.8 B |
| Low | 72.645 | Growth% | 9.09 |
| P/e | 16.808 | Volume | 8.1 M |
| P/b | 1.71 | Market Capital | 163.9 B |
| Highest High | Lowest Low | ||
| 50 Days Moving Average | 76.32 (as of 21/12/2022) | 50 Days Moving Average Percentage | -4.3141060688901 (as of 21/12/2022 |
| Industry: Major Pharmaceuticals |
Charts for balance Sheet:
Balance Sheet Table: last 5 years
Note: Numbers are estimated, Exact figures can be found in Annual Reports
| Type | Year1 / 2017 | Year2 / 2018 | Year3 / 2019 | Year4 / 2020 | Current Year / 2021 |
| Revenue | 20.7 B | 22.5 B | 26.1 B | 42.5 B | 46.3 B |
| Cap Spending | -1.0 B | -951.0 M | -836.0 M | -753.0 M | -973.0 M |
| Operating Expenses | 9.5 B | 10.0 B | 13.0 B | 37.6 B | 28.3 B |
| Operating Cash Flow | 5.1 B | 5.9 B | 4.9 B | -6.8 B | 8.0 B |
| Free Cash Flow | 4.2 B | 4.9 B | 7.2 B | 13.2 B | 15.2 B |
| Free Cash Flow Per Share | 2.585 | 3.056 | 3.203 | 5.936 | 6.989 |
| Total liabilities | 7.9 B | 7.3 B | 46.7 B | 50.6 B | 44.5 B |
| Total cash | 5.4 B | 6.9 B | 12.3 B | 14.5 B | 13.9 B |
| ROE% | 0.072 | 0.373 | 0.137 | -0.193 | 0.19 |
| Outstanding Shares | 1.6 B | 1.6 B | 2.2 B | 2.2 B | 2.1 B |
| P/E | 103.548 | 16.808 | 41.993 | -14.912 | 20.924 |
| P/S | 5.019 | 3.665 | 5.524 | 3.162 | 3.155 |
| Revenue USD | 20.7 B | 22.5 B | 26.1 B | 42.5 B | 46.3 B |
| NO REPORTS FOR THIS STOCK |
Latest Searches
| Stock | Close Price | %of value | Date |
|---|